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Summary The clinicopathological features of malignant cells are sometimes modified by autologous cytokine
production. Inflammatory fibrous histiocytoma (IFH) is characterised by leukocyte infiltration and is a variant
of malignant fibrous histiocytoma (MFH). We demonstrated that three MFH cell lines (MF-1, MF-3, and
MF-4) have the potential to promote neutrophil chemotaxis and to express mRNA for the cytokines,
granulocyte-macrophage colony stimulating factor (GM-CSF) and/or interleukin 8/neutrophil attractant/
activation protein 1 (IL-8/NAP-1), both with and without interleukin 1p (IL-1p) stimulation. MF-1 cells
showed the spontaneous production of neutrophil chemotactic activity and the expression of both of GM-CSF
and IL-8/NAP-1 mRNA, which was enhanced by exogenous IL-1p. In contrast, MF-3 cells showed the
expression of GM-CSF and IL-8/NAP-1 mRNA with IL-1p stimulation but not without it, and MF-4 cells
expressed only IL-8/NAP-1 mRNA when stimulated with IL-1lB (time- and dose-dependent expression). These
findings suggest that neutrophil chemotactic cytokines derived from IFH cells might be responsible for the
prominent infiltration of neutrophils in this disease.
The demonstration of abnormal expression of CSFs or CSF-
like substances by malignant cells and the establishment of
CSF-producing cell lines have been reported (Gheradi et al.,
1985; Isoda & Yasumoto 1986; Takahashi et al., 1989; Tani
et al., 1990). We recently established a thyroid carcinoma cell
line from a patient with malignant pleurisy and leukocytosis
(Yoshida et al., 1992). GM-CSF and IL-8/NAP-1, which
augment neutrophil chemotaxis (Yoshimura et al., 1987;
Wang et al., 1987), were spontaneously produced by this cell
line, suggesting that modification of the clinicopathological
features of this malignancy may have occurred in relation to
these two cytokines. Infiltration of neutrophils is known to
be one of the major findings in MFH, a disease with a great
variety of clinical and histological features (Weiss & Enz-
inger, 1978). There are some variants accompanied by the
prominent infiltration of neutrophils, which are known as
inflammatory fibrous histiocytoma (IFH). Neutrophil
chemotactic activity was recently demonstrated in a case of
IFH with leukemoid reaction (Tani et al., 1990).
The infiltration of monocytes-macrophage into the tumour
is a typical feature of MFH (Weiss & Enzinger, 1978).
Among the several active cytokines secreted by infiltrating
macrophages, IL-1 and tumour necrosis factor (TNF) are
likely to be an important in inflammation and tissue damage
(Oppenheim et al., 1986; Le & Vilcek, 1987). Stimulation by
exogenious IL-1 and TNF can induce promotion and
modification of production of GM-CSF and IL-8/NAP-1 in
various cells (Munker et al., 1986; Zucali et al., 1986; Mat-
sushima et al., 1988; Strieter et al., 1989; Brennan et al.,
1990; Seitz et al., 1991; Zoja et al., 1991; Meir et al.,
1992).
In this paper, we examined neutrophil chemotactic factor
production by MFH cell lines and their expression of GM-
CSF and IL-8/NAP-1 mRNA with or without IL-1p stimula-
tion.
Materials and methods
Cell lines
The three human MFH cell lines (MF-1, MF-3, MF-4) were
established by H. Okabe (Okabe et al., 1987; Takeya et al.,
1991) and MF-SH was the generous gift of Dr K. Shirasuna
(Shirasuna et al., 1985). The Human thyroid carcinoma cell
line, KHM-5M (Yoshida et al., 1992) was used as a positive
control for GM-CSF and IL-8/NAP-1 expression, and a
human multiple myeloma cell line, KHM-7 established in our
laboratory was used as the negative control.
Culture conditions
Cells were grown to confluence in 25 mm2 flasks at 37'C in
humidified 95% air/5% C02, using RPMI 1640 medium
containing 10% fetal bovine serum (FBS) as the culture
medium. On the day of use cells were washed with
RPMI1640 medium and incubated with IL-1p in RPMI1640
medium containing 0.1% bovine serum albumin (BSA) for
the specified times and doses. Cell-free supernatants were
harvested, dialysed with Dulbecco's calcium- and
magnesium-free phosphate-buffered saline (CMF-PBS)
(pH.7.4), and then tested for neutrophil chemotactic activity.
Total cellular RNA was extracted from 1-2 x 107 cells and
analysed as described below.
Reagent preparation
Human IL-1p, with a specific activity of 2 x 107 UMmg', was
a generous gift of Otsuka Parmaceutical Co. Ltd. (Tokyo,
Japan). Dilutions of this cytokine were prepared in CMF-
PBS with 0.1% BSA.
Chemotaxis assay
Heparinised human venous blood from healthy volunteers
was layered on to Ficoll-Conray (specific gravity 1.078) and
centrifuged at 400 g for 30 min. Polymorphonuclear cell
(PMN)-rich pellets were collected and the contaminating
erythrocytes were lysed by treatment with 0.85% (w/v)
NH4Cl (pH7.0) for 5 min at room temperature. The PMN
were then washed three times and suspended in RPMI1640
medium at 1 x 106 cellsml-'. PMN contained more than
92% neutrophils and 5% eosinophils, and the viability was
confirmed to be more than 98% by trypan blue dye ex-
clusion.
Neutrophil chemotaxis activity experiments were set up in
multiwell chemotasis chambers (Neuro Probe. Inc., Bethesda,
MD) (Harvath et al., 1980). Briefly, 25 gl aliquots of speci-
mens in CMF-PBS with 0.1% BSA were placed into triplet
wells. A polycarbonate filter with 3ytm pores (polyvinyl-
pyrrolidone-free, Nucleopore Corp., Pleasanton, CA) was
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placed in the chamber and 50 il of the neutrophil suspension
was then added to the top part of each well. The chemotaxis
chambers were incubated at 37'C in humidified 95% air/5%
CO2 for 40 min. The filters were removed, fixed in 99%
methanol, and stained with May-Gruwald-Giemsa stain.
Neutrophils migrating through the bottom of the filter were
counted in five different high-power fields (x 400). Neut-
rophil chemotactic activity was standardised and expressed as
a percentage of the positive control, which was 10- M N-
formylmethionyl-leucyl-phenylalanine (FMLP) (Sigma
Chemical Co., MO) in CMF-PBS with 0.1% BSA. CMF-
PBS with 0.1% BSA always gave a value of 10-15% of the
positive control, and was used as the negative control. All
experiments were carried out in triplicate.
Northern blot analysis
Total cellular RNA was extracted from cells using the
guanidine thiocynate/caesium chloride method (Southern,
1979). The RNA (10 gg) was then denatured by heating at
60'C for 20 min in 50% formamide and 26fgml-' ethidium
bromide, and processed by electrophoresis on 1% agarose gel
containing 2.2 M formaldehyde. After transferring the RNA
to nitrocellulose filters, the filters were baked for 2h at 80°C.
After being prehybridised at 42'C in 5 x standard saline
citrate (SSC), 5 x Denhart's solution, 50% formamide,
20 mM sodium phosphate buffer, and heat-denatured salmon
sperm DNA (200figml-'), the filters were hybrised with a
32P-labelled c-DNA probe at 42°C for 16h. They were then
washed three times at room temperature with 5 x SSC/0.1%
sodium dodecyl sulfate (SDS) and washed again at 56°C with
0.1 x SSC/0.1% SDS. Finally, the filters were exposed to
X-ray film overnight at - 70'C with an intensifying screen.
The relative intensities of radiographic signals were
quantified by using laser densitometry (CS-900, Simazu,
Kyoto, Japan). Equivalent amounts of total RNA per
amount of gel were assessed by monitoring 28S and 18S
rRNA.
Table I Neutrophil chemotactic activity of the conditioned medium
of MFH cell lines stimulated by IL-lp
Cell line Medium only + ILIP"
MF-1 57.2 ± 4.45 92.3 ± 7.53b
MF-3 35.2 ± 0.467 35.0 ± 1.89
MF-4 28.1 1.46 86.2± 6.16c
MF-SH 16.6 1.16 25.9 ± 1.20
CMF-PBS with 0.1% BSA always gave a value of 10-15% of the
positive control, and was used as the negative control. aEach cell line
was challenged with 10 u ml-' of IL-lb. The supernatants were
recovered after 12 h and then tested for their neutrophil chemotactic
activity. bSignificant elevation of neutrophil chemotactic activity
compared with medium only by Student's t-test (0.005<P<,0.01).
cSignificant elevation of neutrophil chemotactic activity compared
with medium only by Student's t-test (P<0.001).
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Figure 1 Expression of GM-CSF mRNA by IL-lp-treated MFH cell lines and control cell lines. Cells were stimulated at time 0
with 10 Uml-' IL-1Ip, and total cellular RNA was extracted at 12h. Lane 1: MF-l cells without stimulation, lane 2: MF-1 cells
with stimulation, lane 3: MF-3 cells without stimulation, lane 4: MF-3 cells with stimulation, lane 5: MF-4 cells without
stimulation, lane 6: MF-4 cells with stimulation, lane 7: KHM-5M cells without stimulation, lane 8: KHM-5M cells with
stimulation, lane 9: KHM-7 cells with stimulation. a, Northern blot analysis of GM-CSF mRNA expression. b, The signals were
quantified by laser densitometry of the autoradiographs and expressed as a percentage of the maximum value (KHM-5M with
stimulation). c, The nitrocellulose filter used for blotting, with 28S and 18S indicated.
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c-DNA probes
The c-DNA probes for GM-CSF and IL-8/NAP-1 were
obtained from KHM-5M cells by the RNA polymerase chain
reaction (PCR) method based on the published cDNA
sequence (Wong et al., 1985; Matsushita et al., 1988).
Statistical analysis
Data representing the mean ± s.e.m. of three wells are shown
as a percentage of the value for the positive control (10-7 M
FMLP).
Results
Production ofGM-CSF and/or IL-8/NAP-1 by MFH cells
stimulated with IL-1p
Confluent MFH cells were stimulated at time 0 with
10 U ml-' of IL-l and the cell-free conditioned medium and
total cellular RNA were recovered 12h later. The super-
natants obtained from the cell lines were dialysed with CMF-
PBS and then tested for their neutrophil chemotactic activity.
As shown in Table I, MF-1 cells yielded significant neutro-
phil chemotactic activity without any IL-1p stimulation. A
significant increase of neutrophil chemotaxis was observed
when MF-I and MF-4 cells were stimulated with IL-1p as
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compared to those cultured with RPMI1640 medium alone.
Moderate augmentation of neutrophil chemotaxis as com-
pared with the negative control was produced by the super-
natant from MF-3 cell cultures whether stimulated with IL-
1P or not. However, stimulated or unstimulated MF-SH
supernatant did not produce any elevation of chemotactic
activity compared with the negative control.
To determine whether the MFH cell lines expressed
mRNA for GM-CSF and/or IL-8/NAP-1, Northern blot
analysis was carried out. KHM-5M cells, which spon-
taneously express both GM-CSF and IL-8/NAP-1 mRNA
(Yoshida et al., 1992), and KHM-7 cells were used as the
positive and negative controls, respectively. As shown in
Figure 1, MF-1 cells demonstrated spontaneous expression of
GM-CSF mRNA and this was significantly elevated by IL-1p
stimulation to 135% of the unstimulated level. Expression of
GM-CSF mRNA was observed in stimulated MF-3 cells, but
not in MF-4 cells (whether stimulated or not). KHM-5M
cells showed spontaneous expression of GM-CSF mRNA,
while KHM-7 cells did not express this mRNA. As shown in
Figure 2, MF-I cells demonstrated the spontaneous expres-
sion of RNA for IL-8/NAP-1 which was stimulated by IL-lp
to 138% of the unstimulated level. IL-lB-treated MF-3 and
MF-4 cells showed the induction of IL-8/NAP-1 mRNA.
RNA for GM-CSF or IL-8/NAP-1 was not observed in
either stimulated or unstimulated MF-SH cells (data not
shown).
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Figure 2 Expression of IL-8/NAP-1 mRNA by IL-lp-treated MFH cell lines and control cell lines. Cells were stimulated at time 0
with 10 Uml-' IL-1p, and total cellular RNA was extracted at 12h. lane 1: MF-l cells without stimulation, lane 2: MF-1 cells with
stimulation, lane 3: MF-3 cells without stimulation, lane 4: MF-3 cells with stimulation, lane 5: MF-4 cells without stimulation,
lane 6: MF-4 cells with stimulation, lane 7: KHM-5M cells without stimulation, lane 8: KHM-5M cells with stimulation, lane 9:
KHM-7 cells with stimulation. a, Northern blot analysis of IL-8/NAP-1 mRNA expression. b, The signals were quantified by laser
densitometry of the autoradiographs and expressed as a percentage of the maximum value (KHM-5M with stimulation). c, The
nitrocellulose filter used for blotting, with 28S and 18S indicated.GM-CSF AND IL-8/NAP-1 EXPRESSION BY MFH 511
Kinetics ofneutrophil chemotacticfactorsproduction by MFH
cell lines
To analyse the kinetics of the production of neutrophil
chemotactic factors by the MFH cell lines, cultured
monolayers were stimulated at time 0 with 10 Uml-' of
IL-1p. Supernatants were recovered at the designated times,
dialysed, and tested for their neutrophil chemotactic activity
(Figure 3). Augmentation of neutrophil chemotaxis was
observed with supernatants of IL-lp-treated MF-I celfs
obtained at any time in the experiment. At both 30 min and
12h of culture, a significant elevation of the chemotactic
activity of MF-l supernatant was noted (about 90% of the
positive control level). Supernatant from IL-l,B-treated MF-3
cells showed a significant elevation of chemotactic activity
from 30 min to 4h of culture (about 65% of the positive
control). However, at 8 and 12h, this activity was decreased
to the same level as that seen without IL-1p stimulation
(about 30% of the positive control). Although supernatant
from IL-l,-treated MF-4 cells did not demonstrate any
elevation of neutrophil chemotactic activity until 8h (about
20-30% of the positive control), it showed a significant
elevation of chemotactic activity at 12h (about 86% of the
positive control).
Time- and dose-dependent expression ofIL-8/NAP-I mRNA
by MF-4 cells
As MF-4 cells produced only IL-8/NAP-1 following IL-lp
stimulation and as IL-8/NAP-1 had auguments neutrophil
chemotaxis more strongly than GM-CSF, we examined the
kinetics of the production and expression of IL-8/NAP-1
mRNA by this cell line. MF-4 cells were stimulated with
10 Uml-' of IL-1,B, and total cellular RNA was extracted at
the designated times and analysed by Northern blotting
(Figure 4). IL-lp-treated MF-4 cells demonstrated a rapid
rise in IL-8/NAP-1 mRNA expression, which reached a max-
imum 4-8h later. There was no expression of IL-8/NAP-1
mRNA by MF-4 cells cultured for 12h without stimulation
(Figure 2). The dose-dependence of the production of IL-8/
NAP-1 mRNA was analysed by increasing the concentration
of IL-1l3 from 0.1 to 100 Uml-1 and culturing confluent
MF-4 cells for 4h. As shown in Figure 5, IL-l,B-treated MF-4
cells demonstrated dose-dependent induction of IL-8/NAP-1
mRNA expression. IL-lp (10 Uml ') caused the maximal
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Figure 4 Kinetic analysis of IL-8/NAP-1 mRNA expression in
MF-4 cells stimulated with 10 Uml-' of IL-1p. a, Northern blot
analysis of IL-8/NAP-1 mRNA expression. b, The signals were
quantified by laser densitometry of the autoradiographs and ex-
pressed as a percentage of the maximum value. c, The nitrocel-
lulose filter used for blotting, with 28S and 18S indicated.
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Figure 3 The neutrophil chemotactic activity of the culture
supernatants of MFH cell lines stimulated with 10 Uml-' of
IL-lp for 12h. Neutrophil chemotactic activity was standardised
by expression as a percentage of the positive control (10-7M
FMLP). The negative control was always 10-15% of the value
of positive control. -0- MF-1, 0- MF-3, - MF-4,
-*- MF-SH.
induction of IL-8/NAP-1 mRNA, as shown by Northern
blotting with densitometry.
Discussion
MFH is the most common soft tissue sarcoma in adult life.
Although it reveals great variations in histiological
appearance, there is always a mixture of histiocytic cells,
fibroblastic cells, and bizarre giant cells in varying propor-
tions. There is also a variant inflammatory type of MFH
which shows the prominent infiltration of neutrophils (IFH).
Some IFH patients have unusual clinical and pathological
features, such as eosinophilia (Serke et al., 1986), neut-
rophilia, and myeloid hyperplasia (Kyriakos & Kempson,
1976; Roques et al., 1979). Previous studies have demon-
strated that bioactive factors which could explain these
clinical features were produced by the MFH cells in vitro.
These include leukotactic factor (Gheradi et al., 1985),
monocyte chemoattractant protein-l (Takeya et al., 1991),
neutrophil chemotactic factor, granulocyte-colony stimulating
factor (Takahashi et al., 1989), eosinophil chemotactic factor,
and eosinophil colony-stimulating factor (Isoda &
Yasumoto, 1986). These previous studies have suggested that512 M. YOSHIDA et al.
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Figure 5 Expression of IL-8/NAP-1 mRNA by MF-4 cells in
response to graded doses of IL-1p. Northern blot a, and den-
sitometric quantification of IL-8/NAP-1 signals. b. A photograph
of the filter showing 28S and 18S rRNA c.
some MFH cells may themselves produce cytokines and thus
modify the clinicopathological features of this disease.
In this study, we demonstrated the variable production of
neutrophil chemotactic activity and the expression of GM-
CSF and/or IL-8/NAP-1 mRNA by some MFH cell lines
both with and without IL-1lB stimulation. MF-l cells pro-
duced neutrophil chemotactic factors and expressed mRNA
for GM-CSF and IL-8/NAP-1 whether or not they were
stimulated with IL-1,8. IL-l,B-treated MF-3 cells showed the
production of neutrophil chemotactic factors and the expres-
sion of both GM-CSF and IL-8/NAP-1 mRNA, while IL-1p-
treated MF-4 cells produced IL-8/NAP-1. In contrast, MF-
SH cells did not show the synthesis of GM-CSF or IL-8/
NAP-1 mRNA. A kinetic analysis of neutrophil chemotactic
activity stimulation by IL-1p showed variations in the man-
ner of induction of such activity in the MFH cell lines. MF-l
showed decrease of neutrophil chemotactic activity at 2-8h
after IL-ip stimulation. MF-3 demonstrated a rapid increase
of chemotactic activity, which then decreased rapidly. It was
considered that the chemotactic activity derived from MF-I
and MF-3 cells was based on more than IL-8/NAP-1 and
GM-CSF release. In MF-4 cells, induction of IL-8/NAP-1
mRNA was observed even after 2h of incubation, but the
relatively late synthesis of neutrophil chemotactic factors was
noted. IL-lp-treated MF-4 cells demonstrated IL-8/NAP-1
mRNA expression in a dose-dependent manner, while dose
of IL-Ip (100 Uml ') suppressed IL-8/NAP-1 mRNA expres-
sion. These results suggest that the neutrophil chemotactic
factors, IL-8/NAP-1 and/or GM-CSF derived from the
tumour cells themselves might be responsible for neutrophil
infiltration into the lesions of IFH patients. There are some
studies reveal the production of IL-8/NAP-1 in rheumatoid
arthritis, neoplastic and infectious disease in vivo (Brennan et
al., 1990; Seitz et al., 1991; Meir et al., 1992). Some IFH cells
might produce GM-CSF and/or IL-8/NAP-1 spontaneously
in the clinical setting. IL-1 was detected in some neoplastics
such as Hodgkin's disease and histiocytic malignancy in vivo
(Hsu & Zhao, 1986). Another possibility is that MFH cells
may be stimulated by IL-ip secreted from themselves or
accessory cells, and then produce GM-CSF and/or IL-8/
NAP-1.
The potency of neutrophil chemotactic factor production
by IFH cell lines might suggest a new approach to investiga-
tion of the pathological and clinical features in this
disease.
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